Norinchukin Bank’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.6M Buy
130,115
+14,479
+13% +$3.74M 0.5% 34
2025
Q1
$25.9M Buy
115,636
+7,721
+7% +$1.73M 0.48% 42
2024
Q4
$24.7M Buy
107,915
+10,313
+11% +$2.36M 0.52% 39
2024
Q3
$23.8M Sell
97,602
-12,215
-11% -$2.98M 0.56% 38
2024
Q2
$21M Buy
109,817
+3,791
+4% +$726K 0.6% 36
2024
Q1
$21M Sell
106,026
-4,494
-4% -$890K 0.63% 34
2023
Q4
$19M Sell
110,520
-41,717
-27% -$7.18M 0.45% 37
2023
Q3
$22.5M Buy
152,237
+43,774
+40% +$6.47M 0.53% 33
2023
Q2
$23.7M Buy
108,463
+7,184
+7% +$1.57M 0.4% 45
2023
Q1
$22.2M Buy
101,279
+8,985
+10% +$1.97M 0.44% 37
2022
Q4
$19.2M Sell
92,294
-24,849
-21% -$5.17M 0.41% 41
2022
Q3
$25.6M Sell
117,143
-438
-0.4% -$95.6K 0.52% 35
2022
Q2
$24.6M Sell
117,581
-14,372
-11% -$3.01M 0.48% 36
2022
Q1
$32M Sell
131,953
-5,097
-4% -$1.24M 0.43% 42
2021
Q4
$35.7M Buy
137,050
+29,554
+27% +$7.7M 0.45% 37
2021
Q3
$28.3M Buy
107,496
+95,465
+793% +$25.2M 0.39% 42
2021
Q2
$2.97M Sell
12,031
-35
-0.3% -$8.63K 0.04% 214
2021
Q1
$2.34M Buy
12,066
+206
+2% +$40K 0.03% 246
2020
Q4
$2.52M Sell
11,860
-286
-2% -$60.8K 0.04% 210
2020
Q3
$2.08M Buy
12,146
+166
+1% +$28.5K 0.03% 228
2020
Q2
$2.3M Sell
11,980
-53
-0.4% -$10.2K 0.04% 184
2020
Q1
$1.77M Sell
12,033
-6,996
-37% -$1.03M 0.03% 198
2019
Q4
$2.95M Sell
19,029
-1,716
-8% -$266K 0.04% 259
2019
Q3
$2.8M Buy
20,745
+542
+3% +$73.2K 0.04% 273
2019
Q2
$2.47M Sell
20,203
-6,995
-26% -$853K 0.04% 289
2019
Q1
$2.83M Buy
27,198
+1,100
+4% +$114K 0.04% 307
2018
Q4
$2.97M Buy
26,098
+7,740
+42% +$881K 0.04% 262
2018
Q3
$2.12M Buy
18,358
+1,216
+7% +$140K 0.03% 305
2018
Q2
$1.78M Buy
17,142
+3,025
+21% +$313K 0.03% 310
2018
Q1
$1.39M Buy
14,117
+2,182
+18% +$215K 0.02% 316
2017
Q4
$1.01M Buy
11,935
+761
+7% +$64.5K 0.02% 393
2017
Q3
$860K Buy
+11,174
New +$860K 0.02% 401